Comparison of the Effect of Tipranavir and Ritonavir or Tipranavir and Ritonavir on the Pharmacokinetic Characteristics of Zidovudine in Healthy Volunteers

NCT02249416 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Tipranavir (TPV) low
DRUG: Ritonavir (RTV) low
DRUG: Tipranavir (TPV) high
DRUG: Ritonavir (RTV) high
DRUG: Zidovudine

Sponsor

Boehringer Ingelheim